AU2002326251A1 - Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate - Google Patents

Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate

Info

Publication number
AU2002326251A1
AU2002326251A1 AU2002326251A AU2002326251A AU2002326251A1 AU 2002326251 A1 AU2002326251 A1 AU 2002326251A1 AU 2002326251 A AU2002326251 A AU 2002326251A AU 2002326251 A AU2002326251 A AU 2002326251A AU 2002326251 A1 AU2002326251 A1 AU 2002326251A1
Authority
AU
Australia
Prior art keywords
clodronate
prophylaxis
treatment
combination
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002326251A
Inventor
Irinel Badea
Tincuta Dinu
Veronica Draghici
Lelia-Georgeta Lazar
Maria Rotaru
Cornelia Stancu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sc Sindan Srl
Original Assignee
S C SINDAN Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S C SINDAN Srl filed Critical S C SINDAN Srl
Publication of AU2002326251A1 publication Critical patent/AU2002326251A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002326251A 2001-07-04 2002-07-02 Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate Abandoned AU2002326251A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ROA200100780A RO121891B1 (en) 2001-07-04 2001-07-04 Pharmaceutical composition for the prophylaxis and treatment of calcium metabolism disorders and process for preparing the same
RO01-00780 2001-07-04
PCT/RO2002/000017 WO2003004008A2 (en) 2001-07-04 2002-07-02 Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate

Publications (1)

Publication Number Publication Date
AU2002326251A1 true AU2002326251A1 (en) 2003-01-21

Family

ID=20129443

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002326251A Abandoned AU2002326251A1 (en) 2001-07-04 2002-07-02 Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate

Country Status (4)

Country Link
EP (1) EP1408934A2 (en)
AU (1) AU2002326251A1 (en)
RO (1) RO121891B1 (en)
WO (1) WO2003004008A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3767998D1 (en) 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh MEDICINAL PRODUCTS CONTAINING CLODRONATE AND METHOD FOR THE PRODUCTION THEREOF.
FI94926C (en) * 1993-11-12 1995-11-27 Leiras Oy Method for preparing a clodronate preparation

Also Published As

Publication number Publication date
WO2003004008A2 (en) 2003-01-16
EP1408934A2 (en) 2004-04-21
RO121891B1 (en) 2008-07-30
WO2003004008A3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
IL219396A0 (en) Compounds for the treatment of metabolic disorders and pharmaceutical compositions containing same
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
TWI345979B (en) Topical pharmaceutical compositions for the treatment of dermatitis
HU0103558D0 (en) Pharmaceutical composition for the treatment of stroke and traumatic brain insury
TWI346558B (en) Pharmaceutical composition for chronic treatment of inflammation and use thereof
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
HUP0400529A3 (en) Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders
IL172621A0 (en) Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
AU2003261328A1 (en) Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
AU2003265010A1 (en) Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
PL362920A1 (en) Therapeutic film forming composition and treatment system
AU2003237969A1 (en) Pharmaceutical composition comprising calcium channel blockers for the treatment of pain
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
IL163871A0 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU2002326251A1 (en) Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate
HUP0204209A3 (en) Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms
AUPR809001A0 (en) Compositions for the treatment and prevention of plant pathogens
HUP0200005A3 (en) Composition for the treatment of psoriasis and process for its preparation
EP1677745A4 (en) Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders
HUP0401294A3 (en) Use of acetyl l-carnitine for the preparation of a pharmaceutical composition for the preventive therapy for pain
IL135993A0 (en) Pharmaceutical composition for the treatment of fibrosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase